The role of GSTM1 gene polymorphisms in lung cancer development in Turkish population
2007

GSTM1 Gene and Lung Cancer in Turkey

Sample size: 256 publication Evidence: low

Author Information

Author(s): Demir Adalet, Altin Sedat, Pehlivan Davut, Demir Mulahim, Yakar Fatih, Seyhan Ekrem Cengiz, Dincer Seyyit Ibrahim

Primary Institution: Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery, Istanbul, Turkey

Hypothesis

Does GSTM1 gene polymorphism influence lung cancer susceptibility in the Turkish population?

Conclusion

GSTM1 genotype is not an independent risk factor for lung cancer.

Supporting Evidence

  • The prevalence of GSTM1-null genotype was 49% in lung cancer patients.
  • The control group had a GSTM1-null genotype prevalence of 52.6%.
  • No significant relationships were found between GSTM1 genotypes and histopathologic types of lung cancers.

Takeaway

This study looked at a gene that might affect lung cancer risk in Turkish people, but it found that having this gene doesn't really change the chances of getting lung cancer.

Methodology

DNA samples were extracted from blood and analyzed using PCR to determine GSTM1 genotypes in lung cancer patients and healthy controls.

Potential Biases

Potential biases due to regional variations in the control population.

Limitations

The study may not account for all genetic and environmental factors influencing lung cancer risk.

Participant Demographics

102 lung cancer patients and 154 healthy controls, with a mean age of 56.3 for patients and 35.1 for controls.

Statistical Information

P-Value

0.57

Confidence Interval

95% CI = 0.70–1.90

Statistical Significance

p > 0.05

Digital Object Identifier (DOI)

10.1186/1477-3163-6-13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication